Product Information
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.1825 per EA under NDC 13107004505. Its NADAC has been published 504 times since Feb 8, 2017.
FDA first approved this application on Jul 15, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107004505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201972FDA Approved
7/15/2013
TE Code
AA
On Market Since
7/15/2013
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 504 times since Feb 8, 2017, and over the history we have for it it has declined 55.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1825 per EA |
|---|---|
| All-time high | $0.4376 (Mar 15, 2017) |
| All-time low | $0.0972 (Jul 21, 2021) |
| 52-week high | $0.1842 |
| 52-week low | $0.1734 |
| Median price | $0.1800 |
| Average price | $0.1985 |
| Largest weekly change | -39.0% (Apr 22, 2020) |
| Weeks tracked | 504 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.1825 per EA (NDC 13107004505), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 55.2%. It has been tracked across 504 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Feb 8, 2017, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0972 (Jul 21, 2021) to a high of $0.4376 (Mar 15, 2017), with a median of $0.1800 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 30% below OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 13107004505) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.